» Articles » PMID: 28347986

Evaluation of a Complex Intervention to Improve Primary Care Prescribing: a Phase IV Segmented Regression Interrupted Time Series Analysis

Overview
Journal Br J Gen Pract
Specialty Public Health
Date 2017 Mar 29
PMID 28347986
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is uncertain whether improvements in primary care high-risk prescribing seen in research trials can be realised in the real-world setting.

Aim: To evaluate the impact of a 1-year system-wide phase IV prescribing safety improvement initiative, which included education, feedback, support to identify patients to review, and small financial incentives.

Design And Setting: An interrupted time series analysis of targeted high-risk prescribing in all 56 general practices in NHS Forth Valley, Scotland, was performed. In 2013-2014, this focused on high-risk non-steroidal anti-inflammatory drugs (NSAIDs) in older people and NSAIDs with oral anticoagulants; in 2014-2015, it focused on antipsychotics in older people.

Method: The primary analysis used segmented regression analysis to estimate impact at the end of the intervention, and 12 months later. The secondary analysis used difference-in-difference methods to compare Forth Valley changes with those in NHS Greater Glasgow and Clyde (GGC).

Results: In the primary analysis, downward trends for all three NSAID measures that were existent before the intervention statistically significantly steepened following implementation of the intervention. At the end of the intervention period, 1221 fewer patients than expected were prescribed a high-risk NSAID. In contrast, antipsychotic prescribing in older people increased slowly over time, with no intervention-associated change. In the secondary analysis, reductions at the end of the intervention period in all three NSAID measures were statistically significantly greater in NHS Forth Valley than in NHS GGC, but only significantly greater for two of these measures 12 months after the intervention finished.

Conclusion: There were substantial and sustained reductions in the high-risk prescribing of NSAIDs, although with some waning of effect 12 months after the intervention ceased. The same intervention had no effect on antipsychotic prescribing in older people.

Citing Articles

Use of prescribing indicators as a means of identifying variation in the prevalence of valproate prescribing between health communities: a cross-sectional study.

Evans A, Hinchliffe A, Hood K, Carson Stevens A Integr Healthc J. 2023; 2(1):e000022.

PMID: 37441310 PMC: 10327459. DOI: 10.1136/ihj-2019-000022.


Feedback of actionable individual patient prescription data to improve asthma prescribing: pragmatic cluster randomised trial in 233 UK general practices.

MacBride-Stewart S, Marwick C, Ryan M, Guthrie B Br J Gen Pract. 2022; .

PMID: 35817581 PMC: 9282800. DOI: 10.3399/BJGP.2021.0695.


Exploration of prescribing error reporting across primary care: a qualitative study.

Hall N, Bullen K, Sherwood J, Wake N, Wilkes S, Donovan G BMJ Open. 2022; 12(1):e050283.

PMID: 35078837 PMC: 8796229. DOI: 10.1136/bmjopen-2021-050283.


The impacts of family physician plan and health transformation plan on hospitalization rates in Iran: an interrupted time series.

Rouhani S, Esmaeili R, Yazdani Charati J, Khandehroo M BMC Health Serv Res. 2021; 21(1):658.

PMID: 34225708 PMC: 8259001. DOI: 10.1186/s12913-021-06685-w.


General practice responses to opioid prescribing feedback: a qualitative process evaluation.

Wood S, Foy R, Willis T, Carder P, Johnson S, Alderson S Br J Gen Pract. 2021; 71(711):e788-e796.

PMID: 33979300 PMC: 8407857. DOI: 10.3399/BJGP.2020.1117.


References
1.
Thomas M . Diuretics, ACE inhibitors and NSAIDs--the triple whammy. Med J Aust. 2000; 172(4):184-5. DOI: 10.5694/j.1326-5377.2000.tb125548.x. View

2.
Stocks S, Kontopantelis E, Akbarov A, Rodgers S, Avery A, Ashcroft D . Examining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research Datalink. BMJ. 2015; 351:h5501. PMC: 4632209. DOI: 10.1136/bmj.h5501. View

3.
Avery A, Dex G, Mulvaney C, Serumaga B, Spencer R, Lester H . Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method. Br J Gen Pract. 2011; 61(589):e526-36. PMC: 3145537. DOI: 10.3399/bjgp11X588501. View

4.
Campbell M, Fitzpatrick R, Haines A, Kinmonth A, Sandercock P, Spiegelhalter D . Framework for design and evaluation of complex interventions to improve health. BMJ. 2000; 321(7262):694-6. PMC: 1118564. DOI: 10.1136/bmj.321.7262.694. View

5.
Guthrie B, Kavanagh K, Robertson C, Barnett K, Treweek S, Petrie D . Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ. 2016; 354:i4079. PMC: 4990081. DOI: 10.1136/bmj.i4079. View